Shuttle Pharmaceuticals Holdings (SHPH) Accumulated Expenses (2022 - 2025)

Shuttle Pharmaceuticals Holdings' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $7854.0 for Q3 2025.

• On a quarterly basis, Accumulated Expenses rose 267.52% year-over-year to $7854.0 in Q3 2025; TTM through Sep 2025 was $7854.0, a 267.52% increase from a year earlier, with the FY2024 full-year figure at $1785.0, down 98.38% from the prior year.
• Accumulated Expenses advanced to $7854.0 in Q3 2025 per SHPH's latest filing, from $590.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $143676.0 in Q1 2024 and bottomed at $590.0 in Q2 2025.
• The 4-year median for Accumulated Expenses is $23328.0 (2023), against an average of $54570.8.
• Across the five-year window, Accumulated Expenses soared 12865.69% in 2023 and tumbled 99.55% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $98135.0 in 2022, then gained by 12.55% to $110453.0 in 2023, then plunged by 98.38% to $1785.0 in 2024, then jumped by 340.0% to $7854.0 in 2025.
• Per Business Quant, the three latest SHPH Accumulated Expenses figures stand at $7854.0 (Q3 2025), $590.0 (Q2 2025), and $7653.0 (Q1 2025).